Abstract Submission
Important Dates
The abstract submission period is from Thursday, January 15 to Tuesday, March 31, 2026 (JST).
Notification of acceptance/rejection: mid-June 2026
Presentation Formats
- Accepted abstracts will be presented in Oral Sessions or Poster Sessions.
- The format (oral/poster) will be determined by the Local Organizing Committee following careful peer review.
- All presentations must be in English.
Abstract Categories
Authors will be asked to select one topic from the list below.
| Main | Sub | ||
|---|---|---|---|
| 1 | Asthma (adult) | a | Mechanisms |
| b | Diagnosis/Epidemiology | ||
| c | Treatment/Management | ||
| 2 | Pediatric Asthma | ||
| 3 | Adult Airway Diseases | ||
| 4 | Atopic Dermatitis | ||
| 5 | Other Skin Diseases | ||
| 6 | Pollinosis | ||
| 7 | Rhinosinusitis | ||
| 8 | Ocular allergy | ||
| 9 | Immunotherapy | ||
| 10 | Molecular Targeted Drug | ||
| 11 | Food Allergy | a | Mechanisms |
| b | Diagnosis/Epidemiology | ||
| c | Treatment/Management | ||
| d | Non-IgE Food Allergy | ||
| e | Food Allergy in Adulthood | ||
| 12 | Eosinophilic Associated Diseases | ||
| 13 | Drug Hypersensitivity | ||
| 14 | Anaphylaxis | ||
| 15 | Allergy Prevention and Risk Factors | ||
| 16 | Immunodeficiency, Collagen Disease and Autoimmune Disease | ||
| 17 | Mechanisms of Allergy and Immune System | ||
| 18 | Animal Models | ||
| 19 | Microbiome and Omics | ||
| 20 | Air Pollution and Environmental Allergies | ||
| 21 | Education and Allied Health | ||
| 22 | Miscellaneous | ||
| 23 | Case Report | ||
Guidelines for Abstract Submission
- Abstracts must be written in English.
- Length requirements:
- -
- Abstract title: maximum of 25 words
- -
- Abstract text: maximum of 250 words
- -
- Authors: maximum 20 authors, including the first author
- -
- Affiliations: maximum 20 institutions
- COI disclosure is required
- Encore presentations presented outside Japan are eligible for submission.
Please indicate whether your presentation is an Encore Presentation on the abstract submission page.
- *
- Presenters are responsible for ensuring the protection of personal privacy during the presentation.
- *
- Your presentations should be based on scientific grounds and be consistent with the contents of the abstract.
- *
- If your presentations fall under the category of clinical researches involving interventions, the researches should be approved by the ethics review committee at each institution.
- *
- The researches should not be intended for commercial use.
Abstract title
All abstract titles must be written in sentence case. Do not include a period at the end of the title or use underlining.
| Example | ✓ | Treatment of food allergy in Japan |
|---|---|---|
| × | TREATMENT OF FOOD ALLERGY in JAPAN. |
Abstract text
Abstracts should be organized containing Background, Methods, Results, and Conclusion.
- A)
- Background:
State the purpose of the study (preferably in one sentence.) - B)
- Methods:
Briefly describe the methods used. For clinical research, include key eligibility criteria for participants. - C)
- Results:
Summarize the results with sufficient detail, including statistical analysis where appropriate. - D)
- Conclusions:
State the conclusions clearly. Statements such as “results will be discussed” or “data will be presented” are not acceptable. - E)
- Others:
Tables, graphs and references should not be included in the abstract.
(Reference can be included in the body of the text.)
Please note:
Abstracts must be proofread carefully to avoid errors before submission.
Affiliations
Affiliations should be indicated in the following manner.
Example:
- -
- Department of Pediatrics, AAA University
- -
- Department of Dermatology, BBB Hospital
- -
- R & D Department, CCC Corporation
- If an abstract does not conform to these guidelines, the Local Organizing Committee may modify it to align with the style of the Japanese Journal of Allergology.
- -
- Working in the field of allergy or clinical immunology
- -
- Either under 35 years of age at the time of the congress (Oct 15,2026) or within 5 years of completing a training program in allergy, asthma, clinical immunology, or a related field
- -
- Currently working or training outside Japan
- -
- Not a Japanese national
- -
- Submitting an abstract to the Joint Congress 2026 as the presenting author during the official submission period, and having it accepted
- -
- Able to present the abstract on-site at the Joint Congress 2026
Conflict-of-Interest Disclosure Policy
Main speaker is asked to show COI status in the first slide or the next slide after introducing presentation title and presenter, or display COI status at the end of poster.
Please download the following file to find the details of COI declaration below.
Notification of Acceptance
Notification of acceptance or rejection will be sent via email by mid-June2026. All correspondence including acceptance/rejection of abstracts, presentation format, date and time of presentation will be informed via email to the email address provided in the abstract submission form.
Abstract Withdrawal
Please notify Secretariat via email at endai-jsajoint2026[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . ) by July 31, 2026 stating the title and number of the abstract to be withdrawn.
Publication of Abstracts
Accepted abstracts will be published in the Japanese Journal of Allergology.
Attendance of Presenters
All accepted abstracts that are not withdrawn before July 31, 2026 must be presented by the author or a designated representative. No-shows may jeopardize submission of future abstracts by the same individuals or institutions.
Format of the Meeting
Speakers are required to attend and present onsite at the Kyoto International Conference Center.
Submission Procedure
Please submit the abstract by clicking the button below.
The online Abstract Submission System does not allow abstract submission using browsers other than Firefox, Google Chrome, Microsoft Edge, and Safari. Please do not use any other browsers. The latest version of each browser is assumed to be used.
1）Abstract reception number and Password
You will need your reception number and password to check and correct your abstract, so make a note of these two displayed on the registration completion screen.
2）Abstract Revisions
Changes to abstracts are accepted up to the submission deadline by using the abstract submission system.
Travel Grants
We welcome participants from around the world. To encourage early-career researchers to travel to Kyoto, the Joint Congress 2026 will offer a limited number of Travel Grants to students and postdoctoral/clinical fellow presenters whose abstracts have been accepted.
Grant Amounts (by region)
| Asia–Oceania (100,000 JPY) | 10 recipients |
| North America (200,000 JPY) | 5 recipients |
| Europe (200,000 JPY) | 5 recipients |
| South America (300,000 JPY) | 3 recipients |
| Middle East & Africa (300,000 JPY) | 3 recipients |
Eligibility
Notes
Abstracts and presentation materials must be prepared entirely in English.
Applicants are responsible for arranging and completing their own visa procedures, if required for entry into Japan.
Application
Application Deadline: March 31, 2026
Submit certification documents signed by your Training Director via the link below.
Personal Information Handling Policy
The information provided during abstract submission will be used for inquiries and communications from the Organizing Committee, as well as for publication in the Conference Proceedings and on the conference website.
It will not be used for any other purposes
Contact Information
For further information, please contact Secretariat at endai-jsajoint2026[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . ).
Secretariat of the JSA/WAO/APAPARI Joint Congress 2026
c/o Japan Convention Services Inc.
